Aria Pharmaceuticals
- Business Model
- B2B
- Last Round
- Venture RoundJan 2021
- Rounds
- 2
About
Aria Pharmaceuticals (formerly twoXAR) is a pre-clinical stage pharmaceutical company that uses a proprietary AI platform to accelerate drug discovery, with a focus on developing cancer cures. The company applies machine learning to identify and prioritize drug candidates, aiming to reduce the time and cost of bringing novel therapies to patients. Aria has been cited alongside leading AI drug discovery firms including Insilico Medicine, Atomwise, and NuMedii.
Summary
Aria Pharmaceuticals is an Artificial Intelligence company based in United States. Its most recent funding was a Venture Round round in Jan 2021. Investors include Andreessen Horowitz.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2021
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...